545 related articles for article (PubMed ID: 18194279)
1. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
Strugala V; Dettmar PW; Pearson JP
Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
[TBL] [Abstract][Full Text] [Related]
2. Colonic mucus, smoking and ulcerative colitis.
Pullan RD
Ann R Coll Surg Engl; 1996 Mar; 78(2):85-91. PubMed ID: 8678464
[TBL] [Abstract][Full Text] [Related]
3. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
[TBL] [Abstract][Full Text] [Related]
4. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
Schmitz-Moormann P; Himmelmann GW; Brandes JW
Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
[TBL] [Abstract][Full Text] [Related]
5. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
6. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
Joo M; Odze RD
Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
[TBL] [Abstract][Full Text] [Related]
7. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
[TBL] [Abstract][Full Text] [Related]
8. Biopsy histamine in ulcerative colitis and Crohn's disease.
Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
[TBL] [Abstract][Full Text] [Related]
9. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases.
Jacobs LR; Huber PW
J Clin Invest; 1985 Jan; 75(1):112-8. PubMed ID: 3965499
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
12. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
[TBL] [Abstract][Full Text] [Related]
13. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
14. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
15. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
[TBL] [Abstract][Full Text] [Related]
16. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
17. Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.
Playford RJ; Hanby AM; Patel K; Calam J
Am J Pathol; 1995 Feb; 146(2):310-6. PubMed ID: 7856742
[TBL] [Abstract][Full Text] [Related]
18. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
19. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.
Pullan RD; Thomas GA; Rhodes M; Newcombe RG; Williams GT; Allen A; Rhodes J
Gut; 1994 Mar; 35(3):353-9. PubMed ID: 8150346
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of Crohn's disease of the colon from ulcerative colitis: ultrastructure study with the scanning electron microscope.
Trabucchi E; Mukenge S; Baratti C; Colombo R; Fregoni F; Montorsi W
Int J Tissue React; 1986; 8(1):79-84. PubMed ID: 3949447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
